News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
CVS Corporation Comments on Caremark Rx Shareholder Approval of CVS/Caremark Merger
March 16, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WOONSOCKET, R.I.--(BUSINESS WIRE)--In response to the results of today’s Caremark Rx, Inc. (NYSE: CMX) shareholder vote approving the CVS/Caremark merger, CVS Corporation (NYSE: CVS) issued the following statement:
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Funding
Recordati fields $12.4B go-private offer
May 22, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Gilead inks $140M API supply deal, tightening ties to Korean manufacturer
May 22, 2026
·
1 min read
·
Nick Paul Taylor
Manufacturing
Roche licensing pact clears generic drugmakers to manufacture antiviral flu drug
May 21, 2026
·
2 min read
·
Nick Paul Taylor
Artificial intelligence
Lilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling
May 21, 2026
·
3 min read
·
Tristan Manalac